Riskpilot← Back to searchSign inGet full accessMigalis ApS
APSActiveCVR 41238267Gøngehusvej 106Research and experimental development on natural sciences and engineering · NACE 7210Est. 20202 employees
Revenue 2024
DKK -34K
+151% vs 2023
EBITDA margin
100.0%
-151% vs 2023
Equity ratio
50.8%
Financial strength
Net profit 2024
DKK -62K
-57% vs 2023
| Revenue | DKK -34K | +151% |
| EBITDA | DKK -34K | -151% |
| Net profit | DKK -62K | -57% |
| Total assets | DKK 841K | +7% |
| Equity | DKK 428K | +3% |
| Employees | 2 | — |
Legal name
Migalis ApS
CVR number
41238267
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5. marts 2020
Share capital
DKK 110.179
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og formanden for bestyrelsen i forening eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at drive virksomhed ved udvikling og markedsføring af biologiske produkter samt anden hermed forbunden virksomhed.
Address
Gøngehusvej 106
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -33 | -32 | -12 | -13 | -34 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -33 | -32 | -12 | -13 | -34 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -33 | -32 | -12 | -13 | -34 |
| Net financials | -2 | -1 | -6 | -26 | -28 |
| Profit before tax | -35 | -32 | -18 | -40 | -62 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -35 | -32 | -18 | -40 | -62 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 513 | 496 | 799 | 786 | 841 |
| Equity | 505 | 473 | 455 | 415 | 428 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 | 24 | 345 | 371 | 414 |
| Total debt | 9 | 24 | 345 | 371 | 414 |
EBITDA margin
-3388600.0%
This company
15.8%
Market median
-21446935% vs market
20202024
Equity ratio
50.8%
This company
38.2%
Market median
+33% vs market
20202024
Return on equity
-14.5%
This company
18.4%
Market median
-179% vs market
20202024
Net profit margin
-6220500.0%
This company
8.1%
Market median
-76796396% vs market
20202024
Asset turnover
-0.04×
This company
1.12×
Market median
-104% vs market
20202024
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-03-05 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IG Management | Management | 2020 | — | — |
ME Management | Management | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2024 | |
KEMPHANSEN HOLDING ApS | Company | 20.0% | 20.0% | 2024 |
GLORIOSA HOLDING ApS | Company | 20.0% | 20.0% | 2026 |
Felantopi ApS | Company | 15.0% | 15.0% | 2026 |
Poul Elgaard Holding 2024 ApS | Company | 5.0% | 5.0% | 2026 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GLORIOSA HOLDING ApS
Migalis ApS Board members of Migalis ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ina Giversen | Management | 0 companies |
| Mads Elgaard Bjørnhof | Management | 0 companies |
| Kasper Hansen | Chairman | 0 companies |